Recent Updates
Recently added Catalysts

ALT-2074

Phase 2

Diabetes | Small Molecules | Cardiovascular |SYNVISTA THERAPEUTICS, INC|Trials Updated: Jul 2, 2008

ALT-2074 development status

Highest phase Phase 2
Registered trials 1 across 1 sponsor since Jun 2007

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedDouble-BlindUNCONTROLLED
Total Trials1
Total Enrollment66

FDA Designations

No designations recorded

ALT-2074 clinical trials

ALT-2074 · 1 trial · 2 indications

Phase 2 1
NCT00491543Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery DiseaseDiabetes
COMPLETED66 Analytics
PHASE2COMPLETED
Evaluation of ALT-2074 in Subjects With Type-2 Diabetes, Haptoglobin Type 2-2 Genotype and Coronary Artery Disease
Diabetes
NCT0049154366
Unlock trial analytics

Study Endpoints

Primary Endpoints

Biomarkers of inflammation and oxidative stress
28 days
Safety
28 days
Pharmacokinetics
28 days
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingDOUBLE
ModelPARALLEL
PurposeTREATMENT

Interventions

NameTypeDescription
ALT-2074DRUG -
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to 75 Years
SexALL
Healthy VolunteersNo
Study Sites2

Inclusion criteria: 1. Male or female, 18 to 75 years of age. 2. Diagnosis of Type 2 diabetes mellitus 3. Stable coronary artery disease (CAD) documented or suspected, not requiring adjustment for ≥2 months, as determined by: a. A history of myocardial infarction verified by Q-wave electrocardiogra...

Countries:United States
Unlock Eligibility Criteria

Competitive Landscape -Diabetes Complications 8 trials (matched to "Diabetes")

No competing companies are currently tracked in active development for Diabetes Complications.
Unlock Competitive Intelligence

Explore more on BiopharmaWatch

SYNVISTA THERAPEUTICS, INC (SYNI)Pipeline, catalysts, financials, insiders and newsDiabetes disease mapEvery company developing for Diabetes, by stage and capitalFDA calendarUpcoming PDUFA dates, AdComs and approval oddsPDUFA calendarEvery scheduled FDA decision date, month by monthHistorical FDA calendarPast decisions and how the stock moved on eachCatalyst SyncUpcoming readouts and decisions, screened by runway and phaseBiotech stock screenerFilter by clinical phase, cash runway and market capDrugs A to ZEvery drug page starting with ACompanies A to ZEvery biotech and pharma company we track